1. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Author
-
DaSilva, Jean, DaSilva, Jean, Decristoforo, Clemens, Mach, Robert, Bormans, Guy, Carlucci, Giuseppe, Al-Qahtani, Mohammed, Duatti, Adriano, Gee, Antony, Szymanski, Wiktor, Rubow, Sietske, Hendrikx, Jeroen, Yang, Xing, Jia, Hongmei, Zhang, Junbo, Caravan, Peter, Yang, Hua, Zeevaart, Jan, Rodriquez, Miguel, Oliveira, Ralph, Zubillaga, Marcela, Sakr, Tamer, Spreckelmeyer, Sarah, DaSilva, Jean, DaSilva, Jean, Decristoforo, Clemens, Mach, Robert, Bormans, Guy, Carlucci, Giuseppe, Al-Qahtani, Mohammed, Duatti, Adriano, Gee, Antony, Szymanski, Wiktor, Rubow, Sietske, Hendrikx, Jeroen, Yang, Xing, Jia, Hongmei, Zhang, Junbo, Caravan, Peter, Yang, Hua, Zeevaart, Jan, Rodriquez, Miguel, Oliveira, Ralph, Zubillaga, Marcela, Sakr, Tamer, and Spreckelmeyer, Sarah
- Abstract
BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. MAIN BODY: This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
- Published
- 2023